Predicting Recurrence and Metastasis in Stage III Colorectal Cancer After Laparoscopic Surgery and Laparotomy

Amar Falsafi, Ali Mohammad Banan Zadeh, Seyed Mohammad Kazem Tadayon, Seyed Vahid Hosseini
116

Views


Abstract

Introduction: Colorectal cancer remains a significant health challenge, particularly in its advanced Stage III. Timely forecasting of recurrence and metastasis in these patients is crucial for optimizing postoperative care and treatment strategies. The aim of this study is to predict the likelihood of recurrence and metastasis in stage III colorectal cancer patients who have undergone laparoscopic surgery and laparotomy.

Material and Methods: In this retrospective analysis, a total of 528 patients with Stage III colorectal cancer were included. Among them, 386 underwent laparoscopy, and 142 underwent laparotomies. logistic regression was employed to assess the influence of the surgical approach on the binary outcomes of recurrence and metastasis. The data were analyzed using SPSS 25, and Odds Ratios along with significance testing were performed with a threshold of p < 0.05 to determine statistical significance.

Results: In the laparoscopy group, the recurrence rate was 23.7%, and although older patients (61-98 years) exhibited a higher risk of recurrence (Odds Ratio:1.88, 95% CI:0.92-3.84, p=0.083), this difference did not reach statistical significance. Gender did not significantly impact recurrence. In the laparotomy group, the recurrence rate was 29.6%, and neither age nor gender had a significant influence on recurrence. Notably, in the laparoscopy group, metastasis was significantly associated with age (Odds Ratio:5.044, 95% CI:2.08-12.23, p=0.001), while gender did not play a significant role in metastasis. Similarly, in the laparotomy group, neither age nor gender significantly affected metastasis.

Conclusion: This study underscores age's influence on recurrence and metastasis rates in laparoscopic treatment for stage III colorectal cancer, highlighting the need for tailored approaches in elderly patients. In contrast, laparotomy seems to be less affected by age, with tumor size emerging as a crucial predictor of disease progression. Surgical approach significantly impacts outcomes in stage III colorectal cancer, with age affecting laparoscopy outcomes more than laparotomy. These findings emphasize the importance of personalized treatments and call for further research to validate results and enhance patient outcomes in advanced colorectal cancer.

Keywords

Colorectal Cancer; Surgical Approach; Laparoscopy; Laparotomy; Recurrence; Metastasis Rates

References

Xi Y, Xu P. Global colorectal cancer burden in 2020 and projections to 2040. Transl Oncol. 2021; 14(10): 101174. PMID: 34243011 DOI: 10.1016/j.tranon.2021.101174

World Cancer Research Fund. Colorectal cancer statistics [Internet]. 2020 [cited: 20 Sep 2023]. Available from: https://www.wcrf.org/cancer-trends/colorectal-cancer-statistics

Gardiner K. Barriers to colorectal cancer screening in people obtaining care from community mental health agencies [PhD Thesis]. Walden University; 2016.

Mungase M, Chaudhury S, Patil AA, Jagtap B, Jain V. Stress, anxiety, depression, and resilience in cancer patients on radiotherapy. Ind Psychiatry J. 2021; 30(2): 346-52. PMID: 35017823 DOI: 10.4103/ipj.ipj_78_20

Durko L, Malecka-Panas E. Lifestyle modifications and colorectal cancer. Curr Colorectal Cancer Rep. 2014; 10(1): 45-54. PMID: 24659930 DOI: 10.1007/s11888-013-0203-4

Yu C, Helwig EJ. The role of AI technology in prediction, diagnosis and treatment of colorectal cancer. Artif Intell Rev. 2022; 55(1): 323-43. PMID: 34248245 DOI: 10.1007/s10462-021-10034-y

Fleming M, Ravula S, Tatishchev SF, Wang HL. Colorectal carcinoma: Pathologic aspects. J Gastrointest Oncol. 2012; 3(3): 153-73. PMID: 22943008 DOI: 10.3978/j.issn.2078-6891.2012.030

Xiao Y, Chen TT, Zhou YL, Zhu SY. Challenges in establishing a strong telemedicine system in China. Postgrad Med J. 2023; 99(1167): 1-3. PMID: 36947420 DOI: 10.1093/postmj/qgac009

Choi DT, Sada YH, Sansgiry S, Kaplan DE, Taddei TH, Aguilar JK, et al. Using telemedicine to facilitate patient communication and treatment decision-making following multidisciplinary tumor board review for patients with hepatocellular carcinoma. J Gastrointest Cancer. 2023; 54(2): 623-31. PMID: 35773376 DOI: 10.1007/s12029-022-00844-w

Foersch S, Lang-Schwarz C, Eckstein M, Geppert C, Schmitt M, Konukiewitz B, et al. pT3 colorectal cancer revisited: A multicentric study on the histological depth of invasion in more than 1000 pT3 carcinomas-proposal for a new pT3a/pT3b subclassification. Br J Cancer. 2022; 127(7): 1270-8. PMID: 35864156 DOI: 10.1038/s41416-022-01889-1

Shanbehzadeh M, Nopour R, Kazemi-Arpanahi H. Comparison of four data mining algorithms for predicting colorectal cancer risk. Journal of Advances in Medical and Biomedical Research. 2021; 29(133): 100-8.

Moulaei K, Sharifi H, Bahaadinbeigy K, Haghdoost AA, Nasiri N. Machine learning for prediction of viral hepatitis: A systematic review and meta-analysis. Int J Med Inform. 2023; 179: 105243. PMID: 37806178 DOI: 10.1016/j.ijmedinf.2023.105243

Karami M, Fatehi M, Torabi M, Langarizadeh M, Rahimi A, Safdari R. Enhance hospital performance from intellectual capital to business intelligence. Radiol Manage. 2013; 35(6): 30-5. PMID: 24475528

Zhu C, Idemudia CU, Feng W. Improved logistic regression model for diabetes prediction by integrating PCA and K-means techniques. Informatics in Medicine Unlocked. 2019; 17: 100179.

Afrash MR, Kazemi-Arpanahi H, Shanbehzadeh M, Nopour R, Mirbagheri E. Predicting hospital readmission risk in patients with COVID-19: A machine learning approach. Informatics in Medicine Unlocked. 2022; 30: 100908.

Shanbehzadeh M, Kazemi-Arpanahi H, Nopour R. Performance evaluation of selected decision tree algorithms for COVID-19 diagnosis using routine clinical data. Med J Islam Repub Iran. 2021; 35: 29. PMID: 34169041 DOI: 10.47176/mjiri.35.29

Matsuda T, Yamashita K, Hasegawa H, Oshikiri T, Hosono M, Higashino N, et al. Recent updates in the surgical treatment of colorectal cancer. Ann Gastroenterol Surg. 2018; 2(2): 129-36. PMID: 29863145 DOI: 10.1002/ags3.12061

Lacy AM, García-Valdecasas JC, Delgado S, Castells A, Taurá P, Piqué JM, Laparoscopy-assisted colectomy versus open colectomy for treatment of non-metastatic colon cancer: A randomised trial. Lancet. 2002; 359(9325): 2224-9. PMID: 12103285 DOI: 10.1016/S0140-6736(02)09290-5

Dehlaghi Jadid K, Cao Y, Petersson J, Angenete E, Matthiessen P. Long term oncological outcomes for laparoscopic versus open surgery for rectal cancer: A population‐based nationwide noninferiority study. Colorectal Dis. 2022; 24(11): 1308-17. PMID: 35656573 DOI: 10.1111/codi.16204

Guillou PJ, Quirke P, Thorpe H, Walker J, Jayne DG, Smith AM, et al. Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial. Lancet. 2005; 365(9472): 1718-26. PMID: 15894098 DOI: 10.1016/S0140-6736(05)66545-2

André T, de Gramont A, Vernerey D, Chibaudel B, Bonnetain F, Tijeras-Raballand A, et al. Adjuvant fluorouracil, leucovorin, and oxaliplatin in stage II to III colon cancer: Updated 10-year survival and outcomes according to BRAF mutation and mismatch repair status of the MOSAIC study. J Clin Oncol. 2015; 33(35): 4176-87. PMID: 26527776 DOI: 10.1200/JCO.2015.63.4238

Martel G, Crawford A, Barkun JS, Boushey RP, Ramsay CR, Fergusson DA. Expert opinion on laparoscopic surgery for colorectal cancer parallels evidence from a cumulative meta-analysis of randomized controlled trials. PLoS One. 2012; 7(4): e35292. PMID: 22532846 DOI: 10.1371/journal.pone.0035292

Yamanashi T, Nakamura T, Sato T, Naito M, Miura H, Tsutsui A, et al. Laparoscopic surgery for locally advanced T4 colon cancer: The long-term outcomes and prognostic factors. Surg Today. 2018; 48(5): 534-44. PMID: 29288349 DOI: 10.1007/s00595-017-1621-8

Lacy AM, García-Valdecasas JC, Delgado S, Castells A, Taurá P, Piqué JM, et al. Laparoscopy-assisted colectomy versus open colectomy for treatment of non-metastatic colon cancer: A randomised trial. Lancet. 2002; 359(9325): 2224-9. PMID: 12103285 DOI: 10.1016/S0140-6736(02)09290-5




DOI: https://doi.org/10.30699/fhi.v12i0.525

Refbacks

  • There are currently no refbacks.